Collecting samples and data from patients with recurrent or metastatic breast cancer
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
This study is collecting blood and tissue samples from patients with recurrent or metastatic breast cancer to learn more about the disease and improve treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT06217874 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather blood samples and fresh tissue from biopsies of metastatic lesions in patients with recurrent or metastatic breast cancer, including male breast cancer. The collected specimens and clinical data will help enhance the understanding of the disease's development, progression, and treatment options. Participants will undergo blood sample collection, tumor biopsy, and have their medical records reviewed as part of the study. The study is being conducted at the Mayo Clinic in Rochester, Minnesota.
Who should consider this trial
Good fit: Ideal candidates include adult males and females with confirmed invasive breast cancer who are willing to participate.
Not a fit: Patients with conditions that impair their ability to provide informed consent or those with serious allergic reactions to local anesthetics may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and treatment options for patients with recurrent or metastatic breast cancer.
How similar studies have performed: Other studies focusing on specimen collection for cancer research have shown success in advancing understanding and treatment, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female participants must have histologically or cytologically confirmed invasive breast cancer. * Male participants must have biopsy proven breast cancer. * Age must be \>= 18 years, and all must be able to understand and willing to sign an informed consent document. Exclusion Criteria: * Dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent; a history of serious or life-threatening allergic reaction to local anesthetics (i.e. lidocaine, xylocaine). * Any other condition, which in the opinion of the patient's treating oncologist, or the physician performing the biopsy procedure, would make participation in this protocol unreasonably hazardous for the patient.
Where this trial is running
Rochester, Minnesota
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Fergus J. Couch, Ph.D. — Mayo Clinic in Rochester
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.